Clayman G - Search Results

1

Genetic progression model for head and neck cancer: implications for field cancerization.

Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Califano J, et al. Among authors: clayman g. Cancer Res. 1996 Jun 1;56(11):2488-92. Cancer Res. 1996. PMID: 8653682

2

Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa.

Clayman GL, Liu FJ, Savage HE, Taylor DL, Lavedan P, Buchsbaum RM, Pellegrino C, Trujillo JM, Young G, Schantz SP. Clayman GL, et al. Arch Otolaryngol Head Neck Surg. 1992 Jan;118(1):41-8. doi: 10.1001/archotol.1992.01880010045014. Arch Otolaryngol Head Neck Surg. 1992. PMID: 1370199

3

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.

Schantz SP, Dimery I, Lippman SM, Clayman GL, Pellegrino C, Morice R. Schantz SP, et al. Among authors: clayman gl. Invest New Drugs. 1992 Aug;10(3):217-23. doi: 10.1007/BF00877250. Invest New Drugs. 1992. PMID: 1428731 Clinical Trial.

4

Glutathione s-transferase genotypes as risk factors for head and neck cancer.

Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H. Trizna Z, et al. Among authors: clayman gl. Am J Surg. 1995 Nov;170(5):499-501. doi: 10.1016/s0002-9610(99)80339-0. Am J Surg. 1995. PMID: 7485742

5

HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.

Beckhardt RN, Kiyokawa N, Xi L, Liu TJ, Hung MC, el-Naggar AK, Zhang HZ, Clayman GL. Beckhardt RN, et al. Among authors: clayman gl. Arch Otolaryngol Head Neck Surg. 1995 Nov;121(11):1265-70. doi: 10.1001/archotol.1995.01890110041008. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7576473

6

Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.

Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Liu TJ, et al. Among authors: clayman gl. Cancer Res. 1995 Jul 15;55(14):3117-22. Cancer Res. 1995. PMID: 7606733

7

Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation.

Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL. Janot F, et al. Among authors: clayman gl. Int J Cancer. 1995 Apr 21;64(2):117-23. doi: 10.1002/ijc.2910640208. Int J Cancer. 1995. PMID: 7615354

8

p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.

Kanjilal S, Strom SS, Clayman GL, Weber RS, el-Naggar AK, Kapur V, Cummings KK, Hill LA, Spitz MR, Kripke ML, et al. Kanjilal S, et al. Among authors: clayman gl. Cancer Res. 1995 Aug 15;55(16):3604-9. Cancer Res. 1995. PMID: 7627969

9

Biology and reversal of aerodigestive tract carcinogenesis.

Lippman SM, Clayman GL, Huber MH, Benner SE, Hong WK. Lippman SM, et al. Among authors: clayman gl. Cancer Treat Res. 1995;74:89-115. doi: 10.1007/978-1-4615-2023-8_5. Cancer Treat Res. 1995. PMID: 7779624 Review. No abstract available.

10

In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. Clayman GL, et al. Cancer Res. 1995 Jan 1;55(1):1-6. Cancer Res. 1995. PMID: 7805018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters